These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 15050090)

  • 1. Impact of psychiatric comorbidity on treatment of adolescent drug abusers.
    Rowe CL; Liddle HA; Greenbaum PE; Henderson CE
    J Subst Abuse Treat; 2004 Mar; 26(2):129-40. PubMed ID: 15050090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychiatric comorbidity and substance use treatment outcomes of adolescents.
    Tomlinson KL; Brown SA; Abrantes A
    Psychol Addict Behav; 2004 Jun; 18(2):160-9. PubMed ID: 15238058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychiatric comorbidity in hospitalized adolescent substance abusers.
    Hovens JG; Cantwell DP; Kiriakos R
    J Am Acad Child Adolesc Psychiatry; 1994 May; 33(4):476-83. PubMed ID: 8005900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of co-occurring substance use on 6 month outcomes for young people seeking mental health treatment.
    Baker KD; Lubman DI; Cosgrave EM; Killackey EJ; Yuen HP; Hides L; Baksheev GN; Buckby JA; Yung AR
    Aust N Z J Psychiatry; 2007 Nov; 41(11):896-902. PubMed ID: 17924242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Major depressive disorder in adolescents: family psychiatric history predicts severe behavioral disinhibition.
    King CA; Knox MS; Henninger N; Nguyen TA; Ghaziuddin N; Maker A; Hanna GL
    J Affect Disord; 2006 Feb; 90(2-3):111-21. PubMed ID: 16352346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adolescent substance abuse and psychiatric comorbidities.
    Deas D
    J Clin Psychiatry; 2006; 67 Suppl 7():18-23. PubMed ID: 16961420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychiatric morbidity and parental substance use disorder.
    Westermeyer J; Yoon G; Thuras P
    Am J Drug Alcohol Abuse; 2006; 32(4):607-16. PubMed ID: 17127549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness.
    Bellack AS; Bennett ME; Gearon JS; Brown CH; Yang Y
    Arch Gen Psychiatry; 2006 Apr; 63(4):426-32. PubMed ID: 16585472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consulting for substance abuse: mental disorders among adolescents and their parents.
    Hodgins S; Tengström A; Bylin S; Göranson M; Hagen L; Janson M; Larsson A; Lundgren-Andersson C; Lundmark C; Norell E; Pedersen H
    Nord J Psychiatry; 2007; 61(5):379-86. PubMed ID: 17990200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral interventions for dual-diagnosis patients.
    Goldsmith RJ; Garlapati V
    Psychiatr Clin North Am; 2004 Dec; 27(4):709-25. PubMed ID: 15550289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of bipolar and substance use disorders in parents of adolescents with bipolar disorder.
    Wilens TE; Biederman J; Adamson J; Monuteaux M; Henin A; Sgambati S; Santry A; Faraone SV
    Biol Psychiatry; 2007 Jul; 62(2):129-34. PubMed ID: 17481590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of comorbid substance use disorders on treatment outcome for anxiety disorders.
    McEvoy PM; Shand F
    J Anxiety Disord; 2008 Aug; 22(6):1087-98. PubMed ID: 18164585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features, response to treatment and functional outcome of bipolar disorder patients with and without co-occurring substance use disorder: 1-year follow-up.
    Mazza M; Mandelli L; Di Nicola M; Harnic D; Catalano V; Tedeschi D; Martinotti G; Colombo R; Bria P; Serretti A; Janiri L
    J Affect Disord; 2009 May; 115(1-2):27-35. PubMed ID: 18845344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethnic differences in comorbidity among substance-abusing adolescents referred to outpatient therapy.
    Robbins MS; Kumar S; Walker-Barnes C; Feaster DJ; Briones E; Szapocznik J
    J Am Acad Child Adolesc Psychiatry; 2002 Apr; 41(4):394-401. PubMed ID: 11931595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substance use and posttraumatic stress disorders: symptom interplay and effects on outcome.
    Read JP; Brown PJ; Kahler CW
    Addict Behav; 2004 Nov; 29(8):1665-72. PubMed ID: 15451135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychiatric comorbidity among adolescents with substance use disorders: findings from the MECA Study.
    Kandel DB; Johnson JG; Bird HR; Weissman MM; Goodman SH; Lahey BB; Regier DA; Schwab-Stone ME
    J Am Acad Child Adolesc Psychiatry; 1999 Jun; 38(6):693-9. PubMed ID: 10361787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics of psychiatrically referred adolescent outpatients with substance use disorder.
    Wilens TE; Biederman J; Abrantes AM; Spencer TJ
    J Am Acad Child Adolesc Psychiatry; 1997 Jul; 36(7):941-7. PubMed ID: 9204672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive and family therapies for adolescent depression: treatment specificity, mediation, and moderation.
    Kolko DJ; Brent DA; Baugher M; Bridge J; Birmaher B
    J Consult Clin Psychol; 2000 Aug; 68(4):603-14. PubMed ID: 10965636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smoking cessation efforts among substance abusers with and without psychiatric comorbidity.
    Unrod M; Cook T; Myers MG; Brown SA
    Addict Behav; 2004 Jul; 29(5):1009-13. PubMed ID: 15219350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.